Oral microbial dysbiosis in cardiovascular diseases
DOI:
https://doi.org/10.12775/JEHS.2023.41.01.013Keywords
cardiovascular diseases, infection, inflammation, oral microbiotaAbstract
The most common diseases in humans are oral infections. Although modern research is mainly concerned with the role of the gut microbiota in systemic diseases, there are also reports indicating that oral infections, and especially periodontal infection, are one of the risk factors for atherosclerotic cardiovascular disease (CVD).The composition of the oral biofilm is a community of several hundred species of bacteria, fungi, spirochetes, viruses and protozoa. It varies depending on the state of health and disease. Pathogenic bacteria in the oral cavity can cause systemic disease by entering the bloodstream or by triggering immune responses at the cellular level. The discovery of the role of the oral microbiome in CVD is leading to new methods of prevention and their treatment. In this review, we discuss the various mechanisms by which oral dysbiosis may contribute to the pathogenesis of CVD as well as available options for their prevention and treatment.
Oral dysbiosis, or the imbalance of bacteria in the oral cavity, has been linked to an increased risk of CVD. Several mechanisms have been proposed to explain how oral dysbiosis may contribute to CVD, including: The production of inflammatory molecules by oral bacteria. The activation of the immune system, which can lead to inflammation throughout the body. The entry of oral bacteria into the bloodstream, where they can travel to other organs and tissues. There are a number of things that can be done to prevent oral dysbiosis and reduce the risk of CVD, including: Good oral hygiene, such as brushing and flossing twice a day. Regular dental checkups and cleanings. Avoiding tobacco use. Eating a healthy diet.
Conclusions. The evidence is growing that oral dysbiosis is a risk factor for CVD. Further research is needed to better understand the mechanisms involved and to develop effective interventions for prevention and treatment. The following are some other important points: The role of oral dysbiosis in CVD is likely to be complex and involve multiple factors. The effects of oral dysbiosis on CVD may vary depending on the individual's overall health status and other risk factors. More research is needed to determine the optimal methods for preventing and treating oral dysbiosis in order to reduce the risk of CVD.
References
Zhang Y, Wang X, Li H, Ni C, Du Z, Yan F. Human oral microbiota and its modulation for oral health. Biomed Pharmacother 2018;99:883-93. https://doi.org/10.1016/j.biopha.2018.01.146.
Sudhakara P, Gupta A, Bhardwaj A, Wilson A. Oral Dysbiotic Communities and Their Implications in Systemic Diseases. Dent J 2018;6:10. https://doi.org/10.3390/dj6020010.
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 2015;15:30-44. https://doi.org/10.1038/nri3785.
Kilian M, Chapple ILC, Hannig M, Marsh PD, Meuric V, Pedersen AML, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J 2016;221:657-66. https://doi.org/10.1038/sj.bdj.2016.865.
Sanz M, Marco Del Castillo A, Jepsen S, Gonzalez-Juanatey JR, D'Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol 2020;47:268-88. https://doi.org/10.1111/jcpe.13189.
Pietiäinen M, Liljestrand JM, Kopra E, Pussinen PJ. Mediators between oral dysbiosis and cardiovascular diseases. Eur J Oral Sci 2018;126:26-36. https://doi.org/10.1111/eos.12423.
Segata N, Haake S, Mannon P, Lemon KP, Waldron L, Gevers D, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012;13:R42. https://doi.org/10.1186/gb-2012- 13-6-r42.
Kilian M. The oral microbiome - friend or foe? Eur J Oral Sci 2018;126:5-12. https://doi.org/10.1111/eos.12527.
Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, et al. The Human Oral Microbiome. J Bacteriol 2010;192:5002-17. https://doi.org/10.1128/JB.00542-10.
Mark Welch JL, Rossetti BJ, Rieken CW, Dewhirst FE, Borisy GG. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci 2016;113. https://doi.org/10.1073/pnas.1522149113.
Sultan AS, Kong EF, Rizk AM, Jabra-Rizk MA. The oral microbiome: A Lesson in coexistence. PLOS Pathog 2018;14:e1006719. https://doi.org/10.1371/journal.ppat.1006719.
McLean JS. Advancements toward a systems level understanding of the human oral microbiome. Front Cell Infect Microbiol 2014;4. https://doi.org/10.3389/fcimb.2014.00098.
Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, et al. Bacterial biofilm and associated infections. J Chin Med Assoc 2018;81:7-11. https://doi.org/10.1016/j.jcma.2017.07.012.
Abisado RG, Benomar S, Klaus JR, Dandekar AA, Chandler JR. Bacterial Quorum Sensing and Microbial Community Interactions. MBio 2018;9:e02331-17. https://doi.org/10.1128/mBio.02331-17.
de la Fuente-Núñez C, Reffuveille F, Fernández L, Hancock RE. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 2013;16:580-9. https://doi.org/10.1016/j.mib.2013.06.013.
Hemmati F, Rezaee MA, Ebrahimzadeh S, Yousefi L, Nouri R, Kafil HS, et al. Novel Strategies to Combat Bacterial Biofilms. Mol Biotechnol 2021;63:569-86. https://doi.org/10.1007/s12033-021-00325-8.
Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the Normal Bacterial Flora of the Oral Cavity. J Clin Microbiol 2005;43:5721-32. https://doi.org/10.1128/JCM.43.11.5721-5732.2005.
Lewis SS, Knelson LP, Moehring RW, Chen LF, Sexton DJ, Anderson DJ. Comparison of Non-Intensive Care Unit (ICU) versus ICU Rates of Catheter-Associated Urinary Tract Infection in Community Hospitals. Infect Control Hosp Epidemiol 2013;34:744-. 7. https://doi.org/10.1086/671000.
Bouzid F, Gtif I, Alfadhli S, Charfeddine S, Ghorbel W, Abdelhédi R, et al. A potential oral microbiome signature associated with coronary artery disease in Tunisia. Biosci Rep 2022;42:BSR20220583. https://doi.org/10.1042/BSR20220583.
Lucchese A. Streptococcus mutans antigen I/II and autoimmunity in cardiovascular diseases. Autoimmun Rev 2017;16:456-60. https://doi.org/10.1016/j.autrev.2017.03.009.
Xie M, Tang Q, Nie J, Zhang C, Zhou X, Yu S, et al. BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress. Circ Res 2020;126. https://doi.org/10.1161/CIRCRESAHA.119.315502.
Beaney T, Schutte AE, Stergiou GS, Borghi C, Burger D, Charchar F, et al. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension 2020;76:333–41. https://doi.org/10.1161/HYPERTENSIONAHA.120.14874.
Gordon JH, LaMonte MJ, Genco RJ, Zhao J, Li L, Hovey KM, et al. Is the Oral Microbiome Associated with Blood Pressure in Older Women? High Blood Press Cardiovasc Prev 2019;26:217-25. https://doi.org/10.1007/s40292-019-00322-8.
Sintim HO, Gürsoy UK. Biofilms as "Connectors" for Oral and Systems Medicine: A New Opportunity for Biomarkers, Molecular Targets, and Bacterial Eradication. OMICS J Integr Biol 2016;20:3-11. https://doi.org/10.1089/omi.2015.0146.
Tonelli A, Lumngwena EN, Ntusi NAB. The oral microbiome in the pathophysiology of cardiovascular disease. Nat Rev Cardiol 2023;20:386-403. https://doi.org/10.1038/s41569-022-00825-3.
Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends Endocrinol Metab 2015;26:315-21. https://doi.org/10.1016/j.tem.2015.03.001.
Imamura T, Potempa J, Tanase S, Travis J. Activation of Blood Coagulation Factor X by Arginine-specific Cysteine Proteinases (Gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 1997;272:16062-7. https://doi.org/10.1074/jbc.272.25.16062.
Kitai T, Tang WHW. Gut microbiota in cardiovascular disease and heart failure. Clin Sci 2018;132:85-91. https://doi.org/10.1042/CS20171090.
Francisqueti-Ferron FV, Nakandakare-Maia ET, Siqueira JS, Ferron AJT, Vieira TA, Bazan SGZ, et al. The role of gut dysbiosis-associated inflammation in heart failure. Rev Assoc Médica Bras 2022;68:1120-4. https://doi.org/10.1590/1806-9282.20220197.
Damgaard C, Reinholdt J, Enevold C, Fiehn N-E, Nielsen CH, Holmstrup P. Immunoglobulin G antibodies against Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans in cardiovascular disease and periodontitis. J Oral Microbiol 2017;9:1374154. https://doi.org/10.1080/20002297.2017.1374154.
Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, et al. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 2009;24:64-8. https://doi.org/10.1111/j.1399-302X.2008.00479.x.
Barrau K, Boulamery A, Imbert G, Casalta J-P, Habib G, Messana T, et al. Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect 2004;10:302-8. https://doi.org/10.1111/j.1198-743X.2004.00776.x.
Tariq M, Alam M, Munir G, Khan MA, Smego RA. Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. Int J Infect Dis 2004;8:163-70. https://doi.org/10.1016/j.ijid.2004.02.001.
Nakatani S, Mitsutake K, Ohara T, Kokubo Y, Yamamoto H, Hanai S, et al. Recent Picture of Infective Endocarditis in Japan: - Lessons From Cardiac Disease Registration (CADRE-IE) -. Circ J 2013;77:1558-64. https://doi.org/10.1253/circj.CJ-12-1101.
Epple M, Enax J, Meyer F. Prevention of Caries and Dental Erosion by Fluorides-A Critical Discussion Based on Physico-Chemical Data and Principles. Dent J 2022;10:6. https://doi.org/10.3390/dj10010006.
Zaura E, Pappalardo VY, Buijs MJ, Volgenant CMC, Brandt BW. Optimizing the quality of clinical studies on oral microbiome: A practical guide for planning, performing, and reporting. Periodontol 2000 2021;85:210-36. https://doi.org/10.1111/prd.12359.
Lassalle F, Spagnoletti M, Fumagalli M, Shaw L, Dyble M, Walker C, et al. Oral microbiomes from hunter-gatherers and traditional farmers reveal shifts in commensal balance and pathogen load linked to diet. Mol Ecol 2018;27:182-95. https://doi.org/10.1111/mec.14435.
Esteban-Fernández A, Zorraquín-Peña I, Ferrer MD, Mira A, Bartolomé B, González De Llano D, et al. Inhibition of Oral Pathogens Adhesion to Human Gingival Fibroblasts by Wine Polyphenols Alone and in Combination with an Oral Probiotic. J Agric Food Chem 2018;66:2071-82. https://doi.org/10.1021/acs.jafc.7b05466.
O'Brien-Simpson NM, Holden JA, Lenzo JC, Tan Y, Brammar GC, Walsh KA, et al. A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis. Npj Vaccines 2016;1:16022. https://doi.org/10.1038/npjvaccines.2016.22.
Ng E, Lim LP. An Overview of Different Interdental Cleaning Aids and Their Effectiveness. Dent J 2019;7:56. https://doi.org/10.3390/dj7020056.
Radaic A, De Jesus MB, Kapila YL. Bacterial anti-microbial peptides and nano-sized drug delivery systems: The state of the art toward improved bacteriocins. J Controlled Release 2020;321:100-18. https://doi.org/10.1016/j.jconrel.2020.02.001.
Teughels W, Newman MG, Coucke W, Haffajee AD, Van Der Mei HC, Haake SK, et al. Guiding Periodontal Pocket Recolonization: a Proof of Concept. J Dent Res 2007;86:1078-82. https://doi.org/10.1177/154405910708601111.
Esteban-Fernández A, Ferrer MD, Zorraquín-Peña I, López-López A, Moreno-Arribas MV, Mira A. In vitro beneficial effects of Streptococcus dentisani as potential oral probiotic for periodontal diseases. J Periodontol 2019;90:1346-55. https://doi.org/10.1002/JPER.18-0751.
Gorr S-U, Abdolhosseini M. Antimicrobial peptides and periodontal disease: Antimicrobial peptides. J Clin Periodontol 2011;38:126-41. https://doi.org/10.1111/j.1600-051X.2010.01664.x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Joanna Osiak, Łukasz Wołowiec, Xawery Żukow, Dagmara Fydrych, Albert Jasniak, Kinga Gawłowska, Agata Staniewska, Grzegorz Grześk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 564
Number of citations: 0
